NEXGEL Toekomstige groei
Future criteriumcontroles 5/6
NEXGEL is forecast to grow earnings and revenue by 69.5% and 34.1% per annum respectively while EPS is expected to grow by 69.5% per annum.
Belangrijke informatie
69.5%
Groei van de winst
69.5%
Groei van de winst per aandeel
Medical Equipment winstgroei | 17.4% |
Inkomstengroei | 34.1% |
Toekomstig rendement op eigen vermogen | n/a |
Dekking van analisten | Low |
Laatst bijgewerkt | 10 Oct 2024 |
Recente toekomstige groei-updates
Recent updates
Winst- en omzetgroeiprognoses
Datum | Inkomsten | Inkomsten | Vrije kasstroom | Geldmiddelen uit operationele activiteiten | Gem. Aantal analisten |
---|---|---|---|---|---|
12/31/2026 | 18 | 5 | N/A | N/A | 1 |
12/31/2025 | 12 | 0 | N/A | N/A | 1 |
12/31/2024 | 9 | -3 | N/A | N/A | 1 |
6/30/2024 | 5 | -3 | -4 | -3 | N/A |
3/31/2024 | 5 | -3 | -4 | -4 | N/A |
12/31/2023 | 4 | -3 | -4 | -3 | N/A |
9/30/2023 | 4 | -3 | -4 | -3 | N/A |
6/30/2023 | 3 | -3 | -4 | -3 | N/A |
3/31/2023 | 2 | -4 | -3 | -3 | N/A |
12/31/2022 | 2 | -5 | -3 | -3 | N/A |
9/30/2022 | 2 | -6 | -4 | -4 | N/A |
6/30/2022 | 2 | -6 | -3 | -3 | N/A |
3/31/2022 | 2 | -5 | -3 | -3 | N/A |
12/31/2021 | 2 | -4 | -3 | -3 | N/A |
9/30/2021 | 1 | -3 | -3 | -2 | N/A |
6/30/2021 | 1 | -3 | -2 | -2 | N/A |
3/31/2021 | 1 | -2 | -2 | -1 | N/A |
12/31/2020 | 1 | -2 | -2 | -2 | N/A |
9/30/2020 | 1 | -2 | -2 | -2 | N/A |
6/30/2020 | 1 | -1 | -2 | -2 | N/A |
3/31/2020 | 1 | -2 | -2 | -2 | N/A |
12/31/2019 | 1 | -2 | -2 | -2 | N/A |
9/30/2019 | 1 | -2 | -1 | -1 | N/A |
6/30/2019 | 1 | -3 | -2 | -2 | N/A |
3/31/2019 | 2 | -2 | -2 | -2 | N/A |
12/31/2018 | 2 | -2 | -2 | -2 | N/A |
9/30/2018 | 2 | -1 | -2 | -2 | N/A |
12/31/2017 | 2 | -1 | N/A | -1 | N/A |
12/31/2016 | 2 | -2 | N/A | -1 | N/A |
Toekomstige groeivoorspellingen analisten
Verdiensten versus spaarpercentage: NXGL is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (2.5%).
Winst versus markt: NXGL is forecast to become profitable over the next 3 years, which is considered above average market growth.
Hoge groeiwinsten: NXGL is expected to become profitable in the next 3 years.
Omzet versus markt: NXGL's revenue (34.1% per year) is forecast to grow faster than the US market (8.9% per year).
Hoge groei-inkomsten: NXGL's revenue (34.1% per year) is forecast to grow faster than 20% per year.
Groeiprognoses winst per aandeel
Toekomstig rendement op eigen vermogen
Toekomstige ROE: Insufficient data to determine if NXGL's Return on Equity is forecast to be high in 3 years time